The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study

Medicine and Dentistry

• All Cause Mortality 100%
• Diabetes 66%
• Follow up 66%
• Observational Study 66%
• Cardiovascular Disease 66%
• Maturity Onset Diabetes of the Young 66%
• Chronic Kidney Disease 33%
• Association 33%
• Age 33%
• Evaluation Study 33%
• Measurement 33%
• Vascular Disease 33%
• Death 33%
• Proportional Hazards Model 33%
• Prognostic Factor 33%
• Urinary System 33%
• Albumin 33%
• End Stage Renal Disease 33%
• Creatinine 33%
• ACE Inhibitor 33%
• Gliclazide 33%
• Indapamide Plus Perindopril 33%
• Diuretic Agent 33%
• Mixed Model 33%